Literature DB >> 11708654

A new beta-lactoglobulin-based vector targets luciferase cDNA expression to the mammary gland of transgenic mice.

M Reichenstein1, H Gottlieb, G M Damari, E Iavnilovitch, I Barash.   

Abstract

A beta-lactoglobulin (BLG)/luciferase gene vector (p907), composed of a luciferase intronless gene inserted between the second and sixth BLG exons was constructed. Stable transfections of CID-9 cells with this vector, as well as with a series of additional vectors, were performed to define regulatory regions within the BLG sequence, and the contribution of the SV40 polyadenylation (PA) site to luciferase expression. A relatively low level of luciferase activity was supported by vector p907. It was partially rescued by vector p906, in which the BLG 3' region, downstream of the luciferase cDNA, was replaced with the SV40 PA site. Flanking the SV40 region of vector p906, at its 3' end, with BLG sequences of exon 6/intron 6/exon 7 and the 3' region of the gene resulted in vector p904. This vector supported the highest luciferase activity, 10 times or 2.5 times higher than that measured in cells transfected with vectors p907 and p906, respectively. The induced activity supported by vector p904 is attributed to interaction between the SV40 PA site and elements of the distal part of the BLG 3' flanking sequences. The BLG 5' regulatory region of vector p904 encompasses a 3-kb promoter sequences. Deletion of 935 bp of its proximal end resulted in a 60% decrease in luciferase activity. Reduced activity was also seen with vector p915 lacking sequences of exon 1/intron 1/exon 2. This decrease could not be rescued with heterologous sequences of insulin intron 1, inserted upstream of the luciferase cDNA. Two sets of transgenic mice carrying vectors p907 and p904 were generated. Vector p907 supported only marginal luciferase activity in the mammary gland of all transgenic mice tested and luciferase RNA could not be detected by northern analysis. In contrast, 50% of the transgenic mice carrying vector p904 expressed luciferase RNA in the mammary gland and tissue-specific, hormonal-dependent activity was determined. However, the new p904 vector was not able to insulate the transgene from surrounding host DNA sequences, as reflected by its copy number-independent manner of expression. Nevertheless, vector p904 may represent a valuable tool for the expression of cDNAs in the mammary gland of transgenic animals.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11708654     DOI: 10.1023/a:1012064922126

Source DB:  PubMed          Journal:  Transgenic Res        ISSN: 0962-8819            Impact factor:   2.788


  43 in total

1.  Chromatin structures of goat and sheep beta-lactoglobulin gene differ.

Authors:  R N Pena; J M Folch; A Sánchez; C B Whitelaw
Journal:  Biochem Biophys Res Commun       Date:  1998-11-27       Impact factor: 3.575

2.  Overexpression of cyclin A in the mammary glands of transgenic mice results in the induction of nuclear abnormalities and increased apoptosis.

Authors:  D M Bortner; M P Rosenberg
Journal:  Cell Growth Differ       Date:  1995-12

Review 3.  Nuclease hypersensitive sites in chromatin.

Authors:  D S Gross; W T Garrard
Journal:  Annu Rev Biochem       Date:  1988       Impact factor: 23.643

4.  Prolactin and insulin synergize to regulate the translation modulator PHAS-I via mitogen-activated protein kinase-independent but wortmannin- and rapamycin-sensitive pathway.

Authors:  I Barash
Journal:  Mol Cell Endocrinol       Date:  1999-09-10       Impact factor: 4.102

5.  Mammalian cDNA and prokaryotic reporter sequences silence adjacent transgenes in transgenic mice.

Authors:  A J Clark; G Harold; F E Yull
Journal:  Nucleic Acids Res       Date:  1997-03-01       Impact factor: 16.971

6.  Position-independent expression of the ovine beta-lactoglobulin gene in transgenic mice.

Authors:  C B Whitelaw; S Harris; M McClenaghan; J P Simons; A J Clark
Journal:  Biochem J       Date:  1992-08-15       Impact factor: 3.857

7.  Temporal control of gene expression in transgenic mice by a tetracycline-responsive promoter.

Authors:  P A Furth; L St Onge; H Böger; P Gruss; M Gossen; A Kistner; H Bujard; L Hennighausen
Journal:  Proc Natl Acad Sci U S A       Date:  1994-09-27       Impact factor: 11.205

8.  Introns increase transcriptional efficiency in transgenic mice.

Authors:  R L Brinster; J M Allen; R R Behringer; R E Gelinas; R D Palmiter
Journal:  Proc Natl Acad Sci U S A       Date:  1988-02       Impact factor: 11.205

9.  Specific combinations of human serum albumin introns direct high level expression of albumin in transfected COS cells and in the milk of transgenic mice.

Authors:  D R Hurwitz; M Nathan; I Barash; N Ilan; M Shani
Journal:  Transgenic Res       Date:  1994-11       Impact factor: 2.788

10.  Functional differentiation and alveolar morphogenesis of primary mammary cultures on reconstituted basement membrane.

Authors:  M H Barcellos-Hoff; J Aggeler; T G Ram; M J Bissell
Journal:  Development       Date:  1989-02       Impact factor: 6.868

View more
  4 in total

1.  Construction of a recombinant human insulin expression vector for mammary gland-specific expression in buffalo (Bubalus bubalis) mammary epithelial cell line.

Authors:  Ramakant Kaushik; Karn Pratap Singh; Archana Kumari; K Rameshbabu; Manoj Kumar Singh; Radhey Shyam Manik; Prabhat Palta; Suresh Kumar Singla; Manmohan Singh Chauhan
Journal:  Mol Biol Rep       Date:  2014-06-27       Impact factor: 2.316

2.  The construction and expression of lysine-rich gene in the mammary gland of transgenic mice.

Authors:  Xin Ma; Peng Zhang; Guangqi Song; Yue Chen; Zhongwei Wang; Yupeng Yin; Delong Kong; Sheng Zhang; Zhihui Zhao; Hongsheng Ouyang; Bo Tang; Ziyi Li
Journal:  DNA Cell Biol       Date:  2012-05-11       Impact factor: 3.311

3.  Expression of recombinant human alpha-lactalbumin in the milk of transgenic goats using a hybrid pomoter/enhancer.

Authors:  Yu-Guo Yuan; Liyou An; Baoli Yu; Shaozheng Song; Feng Zhou; Liqing Zhang; Yinyin Gu; Minghui Yu; Yong Cheng
Journal:  J Anal Methods Chem       Date:  2014-01-09       Impact factor: 2.193

4.  Luminal STAT5 mediates H2AX promoter activity in distinct population of basal mammary epithelial cells.

Authors:  Moshe Reichenstein; Gat Rauner; Shenhav Kfir; Tatiana Kisliouk; Itamar Barash
Journal:  Oncotarget       Date:  2016-07-05
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.